Results 71 to 80 of about 781,343 (307)

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders [PDF]

, 2015
To investigate the long-term disease course of patients with recently deteriorated systemic sclerosis (SSC)-interstitial lung disease (ILD) undergoing continuous immunosuppressive treatment with cyclophosphamide (CYC) as induction ...
BOCCHINO, MARIALUISA, Cappabianca, Salvatore, Cuomo, Giovanna, Iudici, Michele, SANDUZZI ZAMPARELLI, ALESSANDRO, Valentini, Gabriele, Vettori, Serena   +6 more
core   +1 more source

Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease [PDF]

, 2015
Interstitial lung disease (ILD) is a hallmark of systemic sclerosis (SSc). Although high-resolution computed tomography (HRCT) is the gold standard to diagnose ILD, recently lung ultrasound (LUS) has emerged in SSc patients as a new promising technique ...
Amoroso, Antonio, Barbano, Biagio, Barilaro, Giuseppe, Gigante, Antonietta, Giovannetti, Antonello, Lucci, Silvio, Quarta, Silvia, Rosato, Edoardo, ROSSI FANELLI, Filippo   +8 more
core   +1 more source

Progression of fibrosing interstitial lung disease

Respiratory Research, 2020
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an accurate diagnosis has significant implications for both treatment and prognosis.
A. Wong, C. Ryerson, S. Guler
semanticscholar   +1 more source

Fibroblastic Foci in Usual Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease [PDF]

, 2003
A histologic feature of usual interstitial pneumonia is the presence of fibroblastic foci. As some patients with usual interstitial pneumonia and an underlying collagen vascular disease have a better prognosis, we hypothesized that they would have fewer ...
Colby, Thomas V., Flaherty, Kevin R., Gross, Barry H., Kazerooni, Ella A., Lynch, Joseph P. III, Martinez, Fernando J., Mumford, Jeanette A., Murray, Susan, Thannickal, Victor J., Toews, Galen B., Travis, William D.   +10 more
core  

A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach

Journal of Thoracic Disease, 2021
Anti-synthetase syndrome (AS) is a rare autoimmune disorder characterized by the presence of aminoacyl-transfer RNA synthetase antibodies in conjunction with clinical features such as interstitial lung disease (ILD), Raynaud’s phenomenon, nonerosive ...
N. Sawal, S. Mukhopadhyay, Sheetal Rayancha, Alastair Moore, Puneet S Garcha, Anupam Kumar, V. Kaul   +6 more
semanticscholar   +1 more source

Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations [PDF]

, 2014
BACKGROUND: Previous studies investigating a genetic basis for idiopathic pulmonary fibrosis (IPF) have focused on resequencing single genes in IPF kindreds or cohorts to determine the genetic contributions to IPF.
Coghlan, Meghan A, Cole, F. Sessions, Hamvas, Aaron, Huang, Howard J, Mitra, Robi D, Russell, Tonya D, Shifren, Adrian, Wegner, Daniel J, Zhang, Qunyuan   +8 more
core   +3 more sources

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

Trials, 2017
Background Fibrotic interstitial lung diseases (ILDs) are chronic and often progressive conditions resulting in substantial morbidity and mortality. Shortness of breath, a symptom often linked to oxygen desaturation on exertion, is tightly linked to ...
Dina Visca, Vicky Tsipouri, Letizia Mori, Ashi Firouzi, Sharon Fleming, Morag Farquhar, Elizabeth Leung, Toby M. Maher, Paul Cullinan, Nick Hopkinson, Athol U. Wells, Winston Banya, Jennifer A. Whitty, Huzaifa Adamali, Lisa G. Spencer, Piersante Sestini, Elisabetta A. Renzoni   +16 more
doaj   +1 more source

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases

Frontiers in Medicine, 2023
Progressive fibrosing interstitial lung diseases (PF-ILDs) represent a group of conditions of both known and unknown origin which continue to worsen despite standard treatments, leading to respiratory failure and early mortality.
Stefan Cristian Stanel, Stefan Cristian Stanel, Pilar Rivera-Ortega   +2 more
doaj   +1 more source

Smoking-related interstitial lung disease [PDF]

, 2011
Cigarette smoking has a clear epidemiological association with lung diseases, characterised by chronic inflammation of both the bronchiolar and the interstitial lung compartments.
CERRI, Stefania, F. Luppi, RICHELDI, Luca, SPAGNOLO, Paolo   +3 more
core   +1 more source

Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. [PDF]

, 2016
OBJECTIVE: To examine whether lung endothelial cells (ECs) from patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) express mesenchymal cell-specific proteins and gene transcripts, indicative of the occurrence of endothelial-
Arciniegas, Beon, Cooley, Del Galdo, Falke, Gabrielli, Gilbane, Good, Goumans, Hashimoto, Herzog, Herzog, Hinz, Hinz, Humphreys, Jimenez, Katsumoto, Kendall, Kramann, Lamouille, LeBleu, Li, Li, Marelli-Berg, Matucci-Cerinic, McAnulty, Medici, Meeteren, Nolan, Pattanaik, Piera-Velazquez, Piera-Velazquez, Poslethwaite, Ranchoux, Rieder, Strieter, Varga, Veraldi, Wells, Yoshimatsu, Zeisberg, Zeisberg   +41 more
core   +2 more sources